Skip to content

Comment on Paul Krugman: Why markets can’t cure healthcareparent

Comments

I fail to see how having a public plan option would make drug companies stop investing in R&D.

Is it because you think the public plan would negotiate drug rates too low?

Don't the major private insurance plans already negotiate drug rates?

It is true that America is an innovator in health care, but I don't think that will change when the govt is signing the checks.

We also have the best missiles, bombs, and tanks. And all of that is govt funded.

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.